Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
167 participants
OBSERVATIONAL
2019-09-25
2020-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
NCT05698420
Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis
NCT00413803
Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
NCT01575652
Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
NCT02813642
The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients
NCT02747979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dialysis
167 patients diagnosed with CKD and undergoing HD or PD were included in the study
Hemodialysis or peritoneal Dialysis
Hemodialysis or peritoneal Dialysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemodialysis or peritoneal Dialysis
Hemodialysis or peritoneal Dialysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis)
* Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium
* Patient consent to participate
Exclusion Criteria
* Patients not on dialysis treatment
* Missing or incomplete laboratory data
* History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism
* Patients who did not provide consent or could not complete the questionnaire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Çanakkale Onsekiz Mart University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şeyma Eroğlu
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University Hospital, Faculty of Medicine, Department of Internal Medicine, and Department of Nephrology, and Dialysis Unit
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TZ-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.